What is GFI 256?
Guidance for Industry 256 describes the FDA’s approach to situations where veterinarians need
access to drugs compounded from bulk drug substances (BDS) to provide appropriate care for the
medical needs of their patients when no FDA-approved drug can be used.
Projected GFI 256 implementation date is now 4/1/2023.